Evaluation of ankylosing spondylitis quality of life questionnaire: Responsiveness of a new patient-reported outcome measure

Rheumatology

Volumn 51, Issue 4, 2012, Pages 707-714

  Packham, Jon C ^a,b   Jordan, Kelvin P ^a   Haywood, Kirstie L ^c   Garratt, Andrew M ^d   Healey, Emma L ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b HAYWOOD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

Ankylosing spondylitis; Biologic therapies; DMARDs; Outcome measures; Quality of life

Indexed keywords

ETANERCEPT; SULFALAZINE;

ADULT; ANKYLOSING SPONDYLITIS; ANKYLOSING SPONDYLITIS QUALITY OF LIFE QUESTIONNAIRE; ARTICLE; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ACTIVITY; EFFECT SIZE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POSTAL MAIL; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SELF REPORT; SHORT FORM 36; SOCIAL INTERACTION; SOCIAL PARTICIPATION; UNITED KINGDOM; VALIDITY;

ADULT; AGED; ANTIRHEUMATIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERPERSONAL RELATIONS; MALE; MENTAL HEALTH; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 84858687599     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker377     Document Type: Article

References (37)

1. Russell AS. Chapter 14. Ankylosing spondylitis - history. In: Klippel JH, Dieppe PA, eds. Rheumatology, Vol. 1, 2nd edn. London: Mosby, 1998:14.1-2.
2. Ward MM. Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 1998;24:815-27.
3. Maksymowych WP, Gooch KL, Wong RL et al. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis. J Rheumatol 2010;37:385-92.
4. van der Heijde D, Bellamy N, Calin A et al. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997;24:2225-9.
5. van der Heijde D, Calin A, Dougadas M et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol 1999;26:951-4.
6. Fitzpatrick R, Davey C, Buxton MJ et al. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;2:1-74.
7. Naughton MJ, Shumaker SA. The case for domains of function in quality of life assessment. Qual Life Res 2003; 12(Suppl. 1):73-80.
8. Haywood KL, Garratt AM, Healey EL et al. Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL): reliability and validity of a new patient-reported outcome measure. J Rheumatol 2010;10:2100-9.
9. Wolfe BJ, Sirois FM. Beyond standard quality of life measures: the subjective experiences of living with inflammatory bowel disease. Qual Life Res 2008;17: 877-86.
10. Doward LC, Spoorenberg A, Cook SA et al. Development of the ASQoL: a quality of life instruments specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62:20-6.
11. Haywood KL, Garratt AM, Jordan K et al. Disease-specific patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology 2002;41:1295-1302.
12. Haywood KL, Garratt AM, Dziedzic K et al. Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index. J Rheumatol 2003;30:764-73.
13. Haywood KL, Garratt AM, Dawes PT. Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology 2005;44:577-86.
14. McHorney CA, Cohen AS. Equating health status measures with item response theory: illustrations with functional status measures. Med Care 2000;38(Suppl. 9):43-59.
15. Braun J, van der Horst-Bruinsma IE, Huang F et al. Clinical efficacy and safety of etanercept versus sulfasalazine in ankylosing spondylitis patients: a randomised, double-blind study (ACSEND trial). Arthritis Rheum, doi: 10.1002/art.30223.
16. van der Linden SJ, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
17. Healey EL, Haywood KL, Jordan KP et al. Work status and productivity of a cohort of ankylosing spondylitis patients across the United Kingdom. Scand J Rheum 2011;40: 34-40.
18. Healey EL, Haywood KL, Jordan KP et al. Disease severity in ankylosing spondylitis: variation by region and local area deprivation. J Rheum 2010;37:633-8.
19. Garratt AM, Schmidt L, Mackintosh A et al. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 2002;324: 1417-9.
20. Garrett S, Jenkinson T, Kennedy G et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;1:2286-91.
21. Calin A, Garrett S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:281-5.
22. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67: 361-70.
23. Ware JE, Kosinski M, Dewey JE. How to score version two of the SF-36 Health Survey. Lincoln, RI: QualityMetric Inc., 2000.
24. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use, 4th edn. Oxford: Oxford University Press, 2008.
25. Jordan K, Dunn KM, Lewis M et al. A minimal clinically important difference was derived for the Roland-Morris Disability Questionnaire for low back pain. J Clin Epidemiol 2006;59:45-52.
26. Sim J, Jordan K, Lewis M et al. Sensitivity to change and internal consistency of the Northwick Park Neck Pain questionnaire and derivation of a minimal clinically important difference. Clin J Pain 2006;22:820-6.
27. Carr AJ, Higginson IJ. Are quality of life measures patient centred? BMJ 2001;322:1357-60.
28. Bostan EE, Borman P, Bodur H et al. Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2003;23:121-6.
29. Chorus AM, Miedema HS, Boonen A et al. Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 2003;62:1178-84.
30. Dagfinrud H, Mengshoel AM, Hagen KB et al. Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis 2004;63: 1605-10.
31. Bodur H, Ataman S, Rezvani A et al. Quality of life and related variables in patients with ankylosing spondylitis. Qual Life Res 2011;20:543-9.
32. Castel LD, Williams KA, Bosworth HB et al. Content validity in the PROMIS social-health domain: a qualitative analysis of focus-group data. Qual Life Res 2008;17: 737-49.
33. Karapolat H, Akkoc Y, Sari I et al. Comparison of group-based exercise versus home-based exercise in patients with ankylosing spondylitis: effects on Bath Ankylosing Spondylitis Indices, quality of life and depression. Clin Rheum 2008;27: 695-700.
34. Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2004;4:CD002822.
35. Braun J, Baraliakos X, Godolias G et al. Therapy of ankylosing spondylitis-a review. Part I: conventional medical treatment and surgical therapy. Scand J Rheum 2005;34:97-108.
36. de Vet HC, Ostelo RW, Terwee CB et al. Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Qual Life Res 2007;16:131-42.
37. Norman GF, Wyrwich KW, Patrick DL. The mathematical relationship of different forms of responsiveness co-efficients. Qual Life Res 2007;16:815-82.